Clinical Trial Detail

NCT ID NCT03632317
Title A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

malignant glioma

brain stem glioma

Therapies

Everolimus + Panobinostat

Age Groups: child adult

No variant requirements are available.